SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-20-130230
Filing Date
2020-11-30
Accepted
2020-11-30 07:31:10
Documents
6
Period of Report
2020-11-24
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2037264d1_8k.htm 8-K 37737
2 EXHIBIT 10.1 tm2037264d1_ex10-1.htm EX-10.1 56043
3 EXHIBIT 10.2 tm2037264d1_ex10-2.htm EX-10.2 27999
4 EXHIBIT 99.1 tm2037264d1_ex99-1.htm EX-99.1 13291
5 GRAPHIC tm2037264d1_ex10-2img01.jpg GRAPHIC 10599
6 GRAPHIC image_001.jpg GRAPHIC 1788
  Complete submission text file 0001104659-20-130230.txt   153956
Mailing Address 483 BAY STREET N105 TORONTO A6 M5G2C9
Business Address 483 BAY STREET N105 TORONTO A6 M5G2C9 1.416.640.7887
Bionik Laboratories Corp. (Filer) CIK: 0001508381 (see all company filings)

IRS No.: 271340346 | State of Incorp.: DE | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 000-54717 | Film No.: 201356288
SIC: 3842 Orthopedic, Prosthetic & Surgical Appliances & Supplies